跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 50 条关于
“Marinova”
全部
50
临床试验
27
药物
5
机构
7
资讯
11
上个月
Seaweed-Derived Fucoidan Demonstrates Clinically Significant Relief of BPH Symptoms in Randomized Trial
2年前
RYBREVANT® Plus Lazertinib Shows Significant PFS Improvement in EGFR-Mutated NSCLC
去年
MARIPOSA-2: Updated Data on Amivantamab Plus Chemotherapy in EGFR-Mutated NSCLC
去年
TAM Global Appoints Leading Cancer Immunologist Dr. Francesco Marincola as Chief Scientific Officer
7个月前
Kainova Therapeutics Raises $32M CAD to Advance GPCR-Targeting Cancer and Inflammation Therapies
2年前
Osimertinib and Amivantamab Gain FDA Approval for EGFR-Mutated NSCLC
去年
Amivantamab Plus Lazertinib Demonstrates Superior Overall Survival in EGFR-Mutated NSCLC
2个月前
Maricopa County Reports Sharp Increase in West Nile Virus Cases and First Deaths of 2026
9个月前
Updated Survival Data from FLAURA2 and MARIPOSA Trials Reshape Treatment Selection in EGFR-Mutated Advanced NSCLC
6个月前
Kainova Therapeutics Reports Positive Phase I Results for Oral EP4 Receptor Antagonist DT-9081 in Advanced Solid Tumors
第 1 页,共 2 页
上一页
下一页